Top Key Companies for Gefitinib Tablets Market: Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., Shanghai DESANO Pharmaceuticals Holding Co., Ltd., NatcoPharma, AstraZeneca plc, Intelicure Lifesciences, Weefsel Pharma, Taj Pharmaceuticals, Saintroy Lifescience, Actiza Pharmaceutical, Teva.
Global Gefitinib Tablets Market Size was estimated at USD 2271.2 million in 2022 and is projected to reach USD 3043.63 million by 2028, exhibiting a CAGR of 5% during the forecast period.
Global Gefitinib Tablets Market Overview And Scope:
The Global Gefitinib Tablets Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Gefitinib Tablets utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Gefitinib Tablets Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gefitinib Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gefitinib Tablets market.
Global Gefitinib Tablets Market Segmentation
By Type, Gefitinib Tablets market has been segmented into:
Original Drugs
Generic Drugs
By Application, Gefitinib Tablets market has been segmented into:
Breast Cancer
Lung Cancer
Other
Regional Analysis of Gefitinib Tablets Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Gefitinib Tablets Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Gefitinib Tablets market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Gefitinib Tablets market.
Top Key Companies Covered in Gefitinib Tablets market are:
Qilu Pharmaceutical
Sichuan Kelun Pharmaceutical Co.
Ltd.
Jiangsu Hengrui Pharmaceuticals Co.
ltd.
Jiangsu Chia Tai-Tianqing Pharmaceutical Co.
Ltd.
Yangtze River Pharmaceutical (Group) Co.
Ltd.
Jiangsu Tasly Diyi Pharmaceutical Co.
Ltd.
Shanghai DESANO Pharmaceuticals Holding Co.
Ltd.
NatcoPharma
AstraZeneca plc
Intelicure Lifesciences
Weefsel Pharma
Taj Pharmaceuticals
Saintroy Lifescience
Actiza Pharmaceutical
Teva
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Gefitinib Tablets Market by Type
5.1 Gefitinib Tablets Market Overview Snapshot and Growth Engine
5.2 Gefitinib Tablets Market Overview
5.3 Original Drugs
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Original Drugs: Geographic Segmentation
5.4 Generic Drugs
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Generic Drugs: Geographic Segmentation
Chapter 6: Gefitinib Tablets Market by Application
6.1 Gefitinib Tablets Market Overview Snapshot and Growth Engine
6.2 Gefitinib Tablets Market Overview
6.3 Breast Cancer
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Breast Cancer: Geographic Segmentation
6.4 Lung Cancer
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Lung Cancer: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Gefitinib Tablets Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Gefitinib Tablets Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Gefitinib Tablets Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 QILU PHARMACEUTICAL
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SICHUAN KELUN PHARMACEUTICAL CO.
7.4 LTD.
7.5 JIANGSU HENGRUI PHARMACEUTICALS CO.
7.6 LTD.
7.7 JIANGSU CHIA TAI-TIANQING PHARMACEUTICAL CO.
7.8 LTD.
7.9 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO.
7.10 LTD.
7.11 JIANGSU TASLY DIYI PHARMACEUTICAL CO.
7.12 LTD.
7.13 SHANGHAI DESANO PHARMACEUTICALS HOLDING CO.
7.14 LTD.
7.15 NATCOPHARMA
7.16 ASTRAZENECA PLC
7.17 INTELICURE LIFESCIENCES
7.18 WEEFSEL PHARMA
7.19 TAJ PHARMACEUTICALS
7.20 SAINTROY LIFESCIENCE
7.21 ACTIZA PHARMACEUTICAL
7.22 TEVA
Chapter 8: Global Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Original Drugs
8.2.2 Generic Drugs
8.3 Historic and Forecasted Market Size By Application
8.3.1 Breast Cancer
8.3.2 Lung Cancer
8.3.3 Other
Chapter 9: North America Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Original Drugs
9.4.2 Generic Drugs
9.5 Historic and Forecasted Market Size By Application
9.5.1 Breast Cancer
9.5.2 Lung Cancer
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Original Drugs
10.4.2 Generic Drugs
10.5 Historic and Forecasted Market Size By Application
10.5.1 Breast Cancer
10.5.2 Lung Cancer
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Original Drugs
11.4.2 Generic Drugs
11.5 Historic and Forecasted Market Size By Application
11.5.1 Breast Cancer
11.5.2 Lung Cancer
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Original Drugs
12.4.2 Generic Drugs
12.5 Historic and Forecasted Market Size By Application
12.5.1 Breast Cancer
12.5.2 Lung Cancer
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Original Drugs
13.4.2 Generic Drugs
13.5 Historic and Forecasted Market Size By Application
13.5.1 Breast Cancer
13.5.2 Lung Cancer
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Gefitinib Tablets Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Original Drugs
14.4.2 Generic Drugs
14.5 Historic and Forecasted Market Size By Application
14.5.1 Breast Cancer
14.5.2 Lung Cancer
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Gefitinib Tablets Scope:
|
Report Data
|
Gefitinib Tablets Market
|
|
Gefitinib Tablets Market Size in 2025
|
USD XX million
|
|
Gefitinib Tablets CAGR 2025 - 2032
|
XX%
|
|
Gefitinib Tablets Base Year
|
2024
|
|
Gefitinib Tablets Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Qilu Pharmaceutical, Sichuan Kelun Pharmaceutical Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., Shanghai DESANO Pharmaceuticals Holding Co., Ltd., NatcoPharma, AstraZeneca plc, Intelicure Lifesciences, Weefsel Pharma, Taj Pharmaceuticals, Saintroy Lifescience, Actiza Pharmaceutical, Teva.
|
|
Key Segments
|
By Type
Original Drugs
Generic Drugs
By Applications
Breast Cancer
Lung Cancer
Other
|
